2011 CBCRP application evaluation process & review committee rosters

The CBCRP thanks the participants in our 2011 review committees for their service and dedication to our Program!

In the first phase of the funding process, grant applications were peer reviewed and scored for scientific merit by review committees using a model that follows established practice at the National Institutes of Health (NIH). Each committee is composed of scientists and advocates from outside California. The Committee Chair leads the review process and is a senior researcher. Scientific Reviewers have broad expertise in topics associated with individual applications. Breast cancer Advocate Reviewers are women active in breast cancer advocacy organizations, and many of them are also living with the disease. Advocates bring their personal knowledge and commitment to the review process. Each committee also includes a California Advocate Observer, who does not review or vote, but represents California’s advocacy community. The observer gains insight into our process and provides feedback to the Program. When additional expertise is needed, an Ad Hoc Member is brought in to the review a particular application not covered by the other committee scientist reviewers.

The CBCRP uses a scientific merit scoring system that rates individual components (e.g., approach, innovativeness, impact). This allows our expert reviewers and Council to better differentiate applications that might otherwise appear identical. Depending on the award type, we use four or five scientific merit components in the peer review process.

We triage some applications that score in the lower range of a committee’s portfolio using the preliminary scores of the assigned reviewers. Applications in the upper range of a committee’s portfolio all receive full committee discussion, as do any of the lower scoring applications nominated to full review by one reviewer.

Applications that were not triaged were rated by the CBCRP’s Council for programmatic responsiveness. The following criteria were used:

This two-tiered evaluation and funding process ensures both scientific excellence and relevance of the research to the CBCRP’s mission and goals.

Community Impact Review Committee

►Chair:
Shiraz I. Mishra, M.B.B.S., Ph.D
Associate Director, Prevention Research Center
Prevention Research Center, Dept of Pediatrics
University of New Mexico
Albuquerque, NM

►Scientific Reviewers:
Sherrie L. Flynt Wallington, Ph.D.
Asst. Prof. of Oncology; Prog. Dir., Health Disparities
Lombardi Comprehensive Cancer Center
Washington, DC

Elmer R. Freeman, M.S.W.
Executive Director
Center for Community Health Education Research and Service
Boston, MA

Carolyn Gotay, Ph.D.
Prof.  & Can. Cancer Soc. Chair in Cancer Primary Prev.
School of Population and Public Health
University of British Columbia
Vancouver, BC Canada

Kathryn M. Kash, Ph.D.
Associate Professor
Thomas Jefferson University
Philadelphia, PA

Reginald Tucker-Seeley, ScD
Research Associate
Center for Community Based Research
Dana-Farber Cancer Institute,
Boston, MA

Mayumi A. Willgerodt, Ph.D.
Associate Professor
Health Sciences Building
University of Washington
Seattle, WA

►Advocate Reviewers:
Beverly Canin
Breast Cancer Option, Inc
Rhinebeck, NY

Susan Pelletier
Vermont Breast Cancer Coalition
Stockbridge, VT

►California Advocate Observers:
Nancy Bellen
Advocate
Santa Rosa, CA

Connie Engel, Ph.D.
Breast Cancer Fund
San Francisco, CA

►Ad-Hoc Reviewers:   
Ellyn E. Matthews, PhD, RN
Assistant Professor
University of Colorado Denver
Aurora, CO

Susan Schneider, PhD, RN
Associate Professor, Lead Faculty Onc Nursing Specialty
Duke University School of Nursing
Durham, NC

Etiology and Prevention Review Committee

►Chair:
Kirsten Moysich, Ph.D.
Prof. of Oncology, Prog Chair, Cancer Pathology & Prev.
Department of Cancer Prevention and Control
Roswell Park Cancer Institute
Buffalo, NY

►Scientific Reviewers:
Stefan Ambs, Ph.D.
Principal Investigator
Laboratory of Human Carcinogenesis
National Cancer Institute
Bethesda, MD

Leena Hilakivi-Clarke, Ph.D.
Associate Professor, Oncology
Georgetown University - Oncology
Washington, DC

Chi-Chen Hong, Ph.D.
Assistant Professor
Department of Cancer Prevention and Control
Roswell Park Cancer Institute
Buffalo, NY

►Advocate Reviewers:
Ann Fonfa
The Annie Appleseed Project
Delray Beach, FL

Sara Williams
The Carolina Breast Cancer Study (UNC)
Mebane, NC     

►California Advocate Observer:
Mary Aalto
USC Norris Cancer Survivorship Advisory Council
Studio City, CA

►Ad-Hoc Reviewers:   
David Euhus, M.D.
Professor, Marilyn R Corrigan Distinguished Chair
UT Southwestern Medical Center at Dallas
Dallas, TX

Francine Laden, Sc.D.
Associate Professor of Environmental Epidemiology
Dept. of Environmental Health & Dept. of Epidemiology
Harvard University
Boston, MA

SRI Chemicals TestingReview Committee

►Chair:
Vincent Cogliano, Ph.D.
Acting Director, Integrated Risk Information System
IRIS - National Cancer Center for Environmental Health
U.S. Environmental Protection Agency
Washington, DC

►Scientific Reviewers:
Stephen Barnes, Ph.D.
Professor
Department of Pharmacology & Toxicology
University of Alabama School of Medicine
Birmingham, AL

Billy W. Day, Ph.D.
Professor and Director, Proteomics Core Lab
Department of Pharmaceutical Sciences
University of Pittsburgh
Pittsburgh, PA

Karam El-Bayoumy, Ph.D.
Distinguished Professor & Assoc. Dir. of Basic Research
Biochemistry and Molecular Biology
Penn State Milton S. Hershey Medical Center
Hershey, PA

Jean Latimer, Ph.D.
Associate Professor of Pharmaceutical Sciences
Health Professions Division, College of Pharmacy
Nova Southeastern University
Fort Lauderdale, FL

Mary Beth Martin, Ph.D.
Professor
Lombardi Cancer Center
Georgetown University School of Medicine
Washington, DC

►Advocate Reviewer:
Anna Cluxton, MBA
Young Survival Coalition
Columbus, OH

SRI Immigration Review Committee

►Chair:
Sarah Gehlert, Ph.D.
E. Desmond Lee Professor of Racial and Ethnic Diversity
The Brown School
Washington University
St. Louis, MO

►Scientific Reviewers:
Francesca Gany, M.D.
Director, Center for Immigrant Health
NYU School of Medicine
New York, NY
 
Shiraz I. Mishra, M.B.B.S., Ph.D
Associate Director, Prevention Research Center
Prevention Research Center, Dept of Pediatrics
University of New Mexico
Albuquerque, NM

Dorothy Pathak, Ph.D.
Professor of Epidemiology and Family Practice
Michigan State University
East Lansing, MI

►Advocate Reviewer:
JoAnn Tsark, MPH
Papa Ola Lokahi
Honolulu, HI

►Ad-Hoc Reviewer:     
Patricia A. Thompson Carino, Ph.D.
Assistant Professor
Arizona Cancer Center
University of Arizona
Tucson, AZ

Treatment, Detection & Prognosis Review Committee

►Chair:
Mark D. Pegram, M.D.
Professor of Medicine and Director of Translational Research
Division of Hematology/Oncology
University of Miami, Sylvester Comprehensive Cancer Center
Miami, FL

►Scientific Reviewers:
Benjamin O. Anderson, M.D.
Professor
Department of Surgery
University of Washington
Seattle, WA

Ralph J. Bernacki, Ph.D.
Professor; Cancer Research Scientist
Department of Pharmacology and Therapeutics
Roswell Park Cancer Institute
Buffalo, NY

Ulrich Bierbach, Ph.D.
Associate Professor
Wake Forest University
Chemistry Department
Winston-Salem, NC

Sandra Demaria, M.D.
Assistant Professor
Department of Pathology
NYU School of Medicine
New York, NY

Kristine Glunde, Ph.D.
Associate Professor of Radiology and Oncology
Johns Hopkins University
Department of Radiology
Baltimore, MD

Eldon R. Jupe, Ph.D.
Vice President, Research
InterGenetics, Incorporated
Oklahoma City, OK

Paul E. Kinahan, Ph.D.
Professor of Radiology
University of Washington
Department of Radiology
Seattle, WA

William Redmond, Ph.D.
Scientist
Robert W. Franz Cancer Research Center
Providence Portland Medical Center
Portland, OR

Fredika M. Robertson, Ph.D.
Professor
M.D. Anderson Cancer Center
Department of Experimental Therapeutics
Houston, TX

Ratna K. Vadlamudi, Ph.D.
Professor
UTHSCSA Department Of Obstetrics & Gynecology
Division of Reproductive Research
San Antonio, TX

Martin C. Woodle, Ph.D.
Scientist President & CSO
Aparna Biosciences Corp.
Bethesda, MD

►Advocate Reviewers:
Roberta C. Gelb
SHARE
New York, NY

Nancy Key
Susan G. Komen Foundation
Camano Island, WA

Kimberly Newman-McCown
Susan G. Komen Foundation
Melrose Park, PA

Beverly Parker, Ph.D.
Y-ME National Breast Cancer Organization
Naperville, IL

►California Advocate Observer
Karuna Jaggar
Breast Cancer Action
San Francisco, CA

►Ad-Hoc Reviewers:          
Silvia C. Formenti, M.D.
Professor of Medicine
NYU Medical Center, School of Medicine
New York, NY

David Mankoff, M.D., Ph.D.
Associate Professor of Radiology
Division of Nuclear Medicine
University of Washington Medical Center
Seattle, WA

Matthew Rowling, Ph.D.
Assistant Professor
Department of Food Science and Human Nutrition
Iowa State University
Ames, IA

John H. Ward, M.D.
Professor and Chief
Huntsman Cancer Institute at the University of Utah
Oncology Division, Department of Internal Medicine
Salt Lake City, UT

Tumor Biology Review Co►Chair:
Harikrishna Nakshatri, Ph.D.
Marian J. Morrison Professor in Breast Cancer Research
Walther Oncology Center
Indiana University School of Medicine
Indianapolis, IN

►Scientific Reviewers:
Hava Avraham, Ph.D.
Associate Professor of Medicine
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, MA

Qihong Huang, M.D., Ph.D.
Assistant Professor
Molecular and Cellular Oncogenesis Program
The Wistar Institute
Philadelphia, PA

Julie E. Lang, M.D.
Assistant Professor of Surgery
Arizona Health Sciences Center
University of Arizona
Tucson, AZ

Joan Lewis-Wambi, Ph.D.
Assistant Professor
Fox Chase Cancer Center
Philadelphia, PA

Cindy K. Miranti, Ph.D.
Scientific Investigator
Van Andel Research Institute
Grand Rapids, MI

Weston W. Porter, Ph.D.
Associate Professor
Texas A&M University
Department of Veterinary Integrative Biosciences
College Station, TX

Patricia Schoenlein, Ph.D.
Associate Professor
Cellular Biology & Anatomy
Medical College of Georgia
Augusta, GA

Joyce A. Schroeder, Ph.D.
Associate Professor
University of Arizona
Department of Molecular & Cellular Biology
Tucson, AZ

►Advocate Reviewers:
Valerie Fraser
Michigan Breast Cancer Coalition
Huntington Woods, MI

Theresa Martyka
Breast Cancer Network of Strength
Chicago Ridge, IL

Nancy Singleton
SHARE
Hoboken, NJ

►California Advocate Observer:
Chira Chen-Tanyolac
University of California, San Francisco
San Francisco, CA

►Ad-Hoc Reviewers:   
James Kaput, Ph.D.
Director, Division/ Personalized Nutrition and Medicine
FDA/NCTR
Jefferson, AR

Thomas Ludwig, Ph.D.
Associate Professor
Columbia University, Institute for Cancer Genetics
Department of Pathology
New York, NY